Publicacións (110) Publicacións de ANTONIO JOSE MERA VARELA

filter_list

2026

  1. Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry

    Rheumatology, Vol. 65, Núm. 1

  2. Erratum to POS1281 IMPLEMENTATION OF AN ELECTRONIC PATIENT-REPORTED OUTCOME MEASURES SYSTEM FOR REMOTE MONITORING IN BIOBADASER: A MULTICENTER REGISTRY OF ADVANCED THERAPIES IN RHEUMATOLOGY [Annals of the Rheumatic Diseases Volume 84, Supplement 1, June 2025, Pages 1328-1329]

    Annals of the Rheumatic Diseases

  3. Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial

    Annals of the Rheumatic Diseases

2025

  1. Correlation between Prevotella intermedia and intraoral metal alloys

    Korean Journal of Orthodontics, Vol. 55, Núm. 4, pp. 327-331

  2. DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

    Scientific Reports, Vol. 15, Núm. 1

  3. Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  4. One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry

    Reumatologia Clinica, Vol. 21, Núm. 5

  5. Risk of Malignancy Related to Ixekizumab in Patients with Psoriatic Arthritis or Axial Spondyloarthropathy: Systematic Review and Meta-analysis

    Journal of Clinical Rheumatology, Vol. 31, Núm. 2, pp. 53-59

2024

  1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

  2. Quantification of temporomandibular joint space in patients with juvenile idiopathic arthritis assessed by cone beam computerized tomography

    Orthodontics and Craniofacial Research, Vol. 27, Núm. 2, pp. 203-210

2023

  1. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression

    Arthritis Research and Therapy, Vol. 25, Núm. 1

2022

  1. Antibodies against 4 Atypical Post-Translational Protein Modifications in Patients with Rheumatoid Arthritis

    Diagnostics, Vol. 12, Núm. 2

  2. Leptin in Osteoarthritis and Rheumatoid Arthritis: Player or Bystander?

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

  3. Progranulin in Musculoskeletal Inflammatory and Degenerative Disorders, Focus on Rheumatoid Arthritis, Lupus and Intervertebral Disc Disease: A Systematic Review

    Pharmaceuticals, Vol. 15, Núm. 12

  4. ROCK inhibition with Y-27632 reduces joint inflammation and damage in serum-induced arthritis model and decreases in vitro osteoclastogenesis in patients with early arthritis

    Frontiers in Immunology, Vol. 13

  5. TMJ contrast enhancement in CBCT images using a new algorithm

    Acta Radiologica Open, Vol. 11, Núm. 1, pp. 205846012210745

  6. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. Monomeric C reactive protein (mCRP) regulates inflammatory responses in human and mouse chondrocytes

    Laboratory Investigation, Vol. 101, Núm. 12, pp. 1550-1560

  2. Pachydermodactyly: a systematic review

    Irish Journal of Medical Science, Vol. 190, Núm. 3, pp. 1005-1014

  3. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome

    Scientific Reports, Vol. 11, Núm. 1